
Purpose
To develop and validate a unified CT–MR foundation-model framework for automated Crohn disease phenotyping and individualized prediction of surgery from routine enterography.
Materials and Methods
In this IRB-approved retrospective multicenter study, CT enterography (CTE) and MR enterography (MRE) examinations were linked to the nationwide Israeli epi-IIRN registry. Ten radiologic findings extracted from reports by a validated language model weakly supervised a modality-conditioned DINOv3 model. The detection cohort comprised 7,170 examinations from 6,282 patients. The prognostic cohort comprised 5,148 examinations from 4,437 patients, including 782 surgeries. Predicted imaging phenotypes and 13 prespecified clinical variables were evaluated with elastic-net Cox models and a nonlinear discrete-time foundation-model head. An enriched clinical comparator added 96 pre-imaging laboratory and medication-history features. Validation included held-out testing, fully nested five-fold validation, leave-one-center-out validation, calibration, and decision-curve analysis.
Results
On held-out testing, macro-AUC was 0.780 (95% CI, 0.751–0.810) for MRE and 0.744 (95% CI, 0.697–0.789) for CTE. Compared with modality-specific models, the unified model showed similar MRE performance (0.780 vs 0.793) and higher CTE performance (0.744 vs 0.673; difference, 0.071 [95% CI, 0.001–0.143]). The primary imaging–clinical Cox model achieved surgery C-indices of 0.791 in the primary analysis and 0.783 (95% CI, 0.766–0.799) under fully nested validation. With enriched clinical variables, adding imaging increased the fully nested C-index from 0.731 to 0.789. The nonlinear discrete-time head achieved 0.813 in the primary analysis and 0.800 under fully nested validation. Leave-one-center-out C-index was 0.754 ± 0.053. Five-year observed and predicted surgery incidences were 13.4% and 13.8%, respectively; decision analysis showed net benefit across thresholds of 5%–50%.
Conclusion
A single CT–MR foundation model automated interpretable Crohn disease phenotyping and improved individualized prediction of surgery beyond clinical data, supporting scalable risk stratification from routine enterography.